CSC (NYSE: CSC) reached an agreement to purchase iSOFT Group Limited (ASX: ISF), an advanced healthcare IT solutions firm, via “court-approved scheme of arrangement.”
According to the firm, “the acquisition will complement and strengthen CSC’s market-leading software products and healthcare integration and services portfolio, while enhancing its healthcare research and development capabilities. It will also accelerate CSC’s strategic growth plan in the Life Sciences market and reinforce the company as a very strong player in healthcare information technology.”
The offer to iSOFT shareholders is listed at $0.17 per share in cash.
“The combination of these companies will further establish CSC as an innovative leader in global healthcare IT, ” CSC CEO Michael W. Laphen said. “Through our combined experience in global healthcare delivery, complementary world-class healthcare software solutions, and enhanced capabilities in system integration, outsourcing and process management, we are forming a compelling lifecycle of services to better serve our global clients and improve patient care.”